In pharmaceutical manufacturing, visual defects such as particulate matter inside sealed drug containers can lead to serious consequences, ranging from regulatory non-compliance to product recalls and patient risk. While automated visual inspection systems are standard for defect detection, they rarely support root-cause identification or in-depth analysis.
CLAIRITY™ VIA bridges this gap with a dedicated visual inspection solution for supplementary forensic analysis. Built on the Nikon SMZ stereo microscope platform and enhanced by the CLAIRITY™ Particle Analysis Suite, VIA enables both manual and automated detection of microscopic particulate analysis in intact vials, prefilled syringes, and translucent sealed vessels—without disturbing the sample.
With three scalable configurations, VIA supports deployment across quality labs, cleanrooms, and investigation hubs. It combines high-resolution optics, digital documentation, and AI-driven detection to deliver a repeatable, traceable process for identifying particulate matter and container-related defects. As an extension of your core inspection protocol, VIA adds speed, consistency, and insight while maintaining compliance with 21 CFR Part 11.
Manual visual inspection is often inconsistent due to operator fatigue or subjectivity. VIA applies AI-guided models to remove guesswork and deliver consistent defect identification across shifts.
Inspecting sealed containers under magnification is slow and repetitive. VIA accelerates the process using real-time imaging, particulate counting, and automated feedback loops to support high-throughput workflows.
Subtle issues like microcracks, fiber contamination, or faint seal scratches are easily missed. VIA integrates advanced optics and machine vision to detect foreign matter at the micron scale with high confidence.
